These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30871322)

  • 1. Co-processed excipients for direct compression of tablets.
    Franc A; Vetchý D; Vodáčková P; Kubaľák R; Jendryková L; Goněc R
    Ceska Slov Farm; 2018 Dec; 67(5-6):175-181. PubMed ID: 30871322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
    Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
    AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
    Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
    Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
    Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K
    Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of rheological and tableting properties of lubricated mixtures of co-processed dry binders for orally disintegrating tablets.
    Tranová T; Macho O; Loskot J; Mužíková J
    Eur J Pharm Sci; 2022 Jan; 168():106035. PubMed ID: 34634469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical evaluation of multipurpose excipients for direct compressed tablet manufacture: comparisons of the capabilities of multipurpose excipients with those in general use.
    Goto K; Sunada H; Danjo K; Yonezawa Y
    Drug Dev Ind Pharm; 1999 Aug; 25(8):869-78. PubMed ID: 10434130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of a new co-processed dry binder based on spray-dried lactose and microcrystalline cellulose.
    Mužíková J; Sináglová P
    Ceska Slov Farm; 2013 Jun; 62(3):127-31. PubMed ID: 23961814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of various processes for simultaneous complexation and granulation to incorporate drug-cyclodextrin complexes into solid dosage forms.
    Gyanani V; Siddalingappa B; Betageri GV
    Drug Dev Ind Pharm; 2015; 41(11):1856-63. PubMed ID: 25754112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tableting technology of a dry extract from Solidago virgaurea L. with the use of silicified microcrystalline cellulose (Prosolv) and other selected auxiliary substances].
    Marczyiński Z
    Polim Med; 2009; 39(4):51-60. PubMed ID: 20099736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing.
    Sohail Arshad M; Zafar S; Yousef B; Alyassin Y; Ali R; AlAsiri A; Chang MW; Ahmad Z; Ali Elkordy A; Faheem A; Pitt K
    Adv Drug Deliv Rev; 2021 Nov; 178():113840. PubMed ID: 34147533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model.
    Viscasillas Clerch A; Fernandez Campos F; Del Pozo A; Calpena Campmany AC
    Drug Dev Ind Pharm; 2013 Jul; 39(7):961-9. PubMed ID: 22607083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of micronized poloxamers as lubricants in direct compression of tablets.
    Muzíková J; Vyhlídalová B; Pekárek T
    Acta Pol Pharm; 2013; 70(6):1087-96. PubMed ID: 24383332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in fundamental and functional properties of HPMC co-processed fillers prepared by fluid-bed coating and spray drying.
    Dong Q; Zhou M; Lin X; Shen L; Feng Y
    Eur J Pharm Sci; 2018 Jul; 119():147-158. PubMed ID: 29626592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
    Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
    Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced dissolution of sildenafil citrate as dry foam tablets.
    Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
    Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S; Meiser F; Morton D; Larson I
    Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of binders in moisture-induced hardness increase in compressed tablets and its effect on in vitro disintegration and dissolution.
    Chowhan ZT
    J Pharm Sci; 1980 Jan; 69(1):1-4. PubMed ID: 7354417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.